Endovascular Aneurysm Repair

Type: Keyphrase
Name: Endovascular Aneurysm Repair
First reported Apr 23 2014 - Updated 23 hours ago - 2 reports

Lombard Medical revives stateside IPO plans with a $55M debut

Lombard's Aorfix stent--Courtesy of Lombard MedicalLombard Medical revived plans to go public with a revised stateside IPO. The news comes less than two weeks after the company decided to postpone its public offering, citing poor market conditions.The ... [Published FierceMedicalDevices - 23 hours ago]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Lombard Signals More Evidence of IPO Market Reality Check

The market for was getting to be a bit ridiculous. Now that volatility has returned in the broader stock market, a reality check is starting to be seen as more IPOs have flopped or been received with a cool reception.Wednesday’s SEC filings show another ... [Published 24/7 Wall St - Apr 23 2014]
First reported Apr 21 2014 - Updated Apr 22 2014 - 1 reports

Medtronic’s Endurant stent graft shows long-term exceptional performance in two studies

US-based Medtronic has reported that the new data from a pair of clinical trials evaluating its Endurant stent graft for abdominal aortic aneurysms affirmed the Endurant stent graft's durable, consistent and proven outcomes endovascular treatment of abdominal ... [Published Medical Devices Business Review - Apr 21 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Endurant AAA Stent Graft from Medtronic Continues Exceptional Long-Term Performance in Observational Studies

New Clinical Data from PANDORA and ENGAGE AffirmMarket-Leading Medical Device's Durable, Consistent and Proven Outcomes MINNEAPOLIS -- April 18, 2014 -- The Endurant AAA stent graft system from Medtronic, Inc. (NYSE:MDT) continues to demonstrate exceptional ... [Published Nasdaq - Apr 18 2014]
Entities: Stent, Medtronic Inc, graft
First reported Apr 11 2014 - Updated Apr 11 2014 - 2 reports

IPOs come to a screeching halt

Those that failed to get out the door: Lombard Medical (EVAR) -- which cited the dreaded "poor market conditions," according to Renaissance Capital -- Scynexis (SCYX), Paycom Software (PAYC), and City Office REIT (CIO).An amended S-1 (called an FWP Amendment) ... [Published MSN Money - Apr 11 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Lombard Medical tables U.S. IPO

by Lombard Medical indefinitely postpones its U.S. initial public offering, citing adverse market conditions.Lombard Medical Technologies  (LON: LMT ) said today that it's tabling a planned initial public offering on the NASDAQ exchange due to adverse ... [Published MassDevice - Apr 11 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Harry Jacobson

WHITING, Ind. - Harry F. "Toppy" Jacobson, 75, of Whiting, formerly of Iron Mountain, passed away peacefully on Sunday, April 6, 2014, at St. Catherine Hospital, East Chicago.Beloved husband of Carol (nee Mikula) Jacobson; loving father of Debbie (Bill) ... [Published The Daily News - Apr 09 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

IPO Calendar 2014: ALLY, LQ, and 12 More Hit the Market This Week

The 2014 IPO calendar will see one of its busiest weeks yet when 14 companies make their public debut this week.According to the research firm Renaissance Capital, 71 companies have already gone public this year. That's an increase of nearly 122% from ... [Published Money Morning - Apr 07 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Mentice at CX2014 - Showing new simulation procedures for EVAR and TEVAR

Mentice at CX2014!Two days to go and our booth has been very well attended.Today our Clinical Director Professor Lars Lönn talks about Endograft limb occlusion in EVAR: When are tortuos iliac arteries an anatomic limitaion? If you are at CX don't miss ... [Published MyNewsDesk - Apr 07 2014]
First reported Apr 03 2014 - Updated Apr 04 2014 - 1 reports

Stent developer TriVascular Technologies sets terms for $91 million IPO

TriVascular Technologies, which develops new stent grafts for endovascular aortic repair ( EVAR ), announced terms for its IPO on Thursday. The Santa Rosa, CA-based company plans to raise $91 million by offering 6.5 million shares at a price range of ... [Published Nasdaq - Apr 03 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

ACC 2014: The future of aortic aneurysm care—PEVAR in the cath lab

April 3, 2014Vanessa Lo, Service Line Strategy AdvisorDuring one scientific session on the future of vascular services, experts highlighted the potential for percutaneous endovascular abdominal aneurysm repair (PEVAR) to impact aortic aneurysm care.Recently, ... [Published The Advisory Board Company - Apr 04 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 2 reports

IPO emigre Lombard Medical looks to raise $60M in a Nasdaq debut

Lombard's Aorfix stent.--Courtesy of Lombard MedicalStentmaker Lombard Medical has set the range for its pending U.S. IPO, aiming to raise $60 million with the sale of 3.6 million shares priced between $15 and $18. U.K.-based Lombard makes an aortic repair ... [Published FierceMedicalDevices - Apr 01 2014]

Quotes

"Several techniques have been attempted to reduce the incidence of vascular injury in large bore vascular access procedures. For example, preoperative imaging of the bloodblood vessel to be accessed, in the form of CT and MR angiography, may provide the physician with an idea of the anatomy of the vessel. If a particular vessel appears on imaging studies to be relatively tortuous or small, possible adjunctive maneuvers to prevent arterial dissection include pre-dilatation angioplasty of the iliofemoral vessels prior to large bore sheath placement, utilization of smaller access sheaths when possible, stiffer wires to aid in sheath placement/withdrawal and/or use of hydrophobic or expandable sheaths. In another attempt at preventing vessel injury, sheath placement may be performed under fluoroscopic guidance, and advancement may be halted when resistance is encountered. Despite the availability of these techniques, vascular injury requiring treatment still occurs in a large percentage of large bore vascular procedures."

More Content

All (45) | News (41) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
"Method and Devices for Flow Occlusion during D... [Published HispanicBusiness.com - 5 hours ago]
Lombard Medical revives stateside IPO plans wit... [Published FierceMedicalDevices - 23 hours ago]
Stent developer Lombard Medical revives IPO pla... [Published Nasdaq - Apr 23 2014]
Lombard Signals More Evidence of IPO Market Rea... [Published 24/7 Wall St - Apr 23 2014]
Medtronic’s Endurant stent graft shows long-ter... [Published Medical Devices Business Review - Apr 21 2014]
Endurant AAA Stent Graft from Medtronic Continu... [Published Investor's Business Daily - Apr 18 2014]
Endurant AAA Stent Graft from Medtronic Continu... [Published Nasdaq - Apr 18 2014]
IPOs come to a screeching halt [Published MSN Money - Apr 11 2014]
Come out wherever you are! Reeling market slams... [Published NBR.com - Apr 11 2014]
Lombard Medical tables U.S. IPO [Published MassDevice - Apr 11 2014]
Biotech IPOs Adamas, Cerulean Slump In Trading ... [Published Investor's Business Daily - Apr 10 2014]
Harry Jacobson [Published The Daily News - Apr 09 2014]
Clinical Decision Support For Cardiology and Im... [Published Diagnostic & Invasive Cardiology - Apr 07 2014]
IPO Calendar 2014: ALLY, LQ, and 12 More Hit th... [Published Money Morning - Apr 07 2014]
16 US IPOs planned for the week of Apr 7 [Published Nasdaq - Apr 07 2014]
US IPO Recap: Chinese mega microblogger Weibo s... [Published Nasdaq - Apr 07 2014]
Mentice at CX2014 - Showing new simulation proc... [Published MyNewsDesk - Apr 07 2014]
Initial public offerings scheduled to debut nex... [Published Belleville News Democrat - Apr 04 2014]
ACC 2014: The future of aortic aneurysm care—PE... [Published The Advisory Board Company - Apr 04 2014]
Stent developer TriVascular Technologies sets t... [Published Nasdaq - Apr 03 2014]
IPO emigre Lombard Medical looks to raise $60M ... [Published FierceMedicalDevices - Apr 01 2014]
Aptus Endosystems Appoints Dr. Bart E. Muhs as ... [Published Enhanced Online News - Apr 01 2014]
Pediatric Interventional Cardiology Market by C... [Published Virtual Strategy Magazine - Apr 01 2014]
Pediatric Interventional Cardiology Market by C... [Published PRWeb - Apr 01 2014]
Lombard Medical sets range for $55m - $65M IPO [Published MassDevice - Mar 31 2014]
Pinterest Hack Ruin Wedding With Butts (Satire) [Published The Guardian Express - Mar 31 2014]
Peripheral Vascular & Interventional Cardiology... [Published Individual.com - Mar 26 2014]
An Indecent Proposal: Microsoft and Red Hat? [Published E-Commerce Times - Mar 24 2014]
Endovascular aneurysm repair outcomes improved ... [Published Orthopedics Today - Mar 24 2014]
Best foot forward [Published MountainXpress - Mar 19 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bucking Trends, Two Medical Device Companies Fi... [Published WSJ.com: Venture Capital Dispatch - Mar 10 2014]
Medical-device companies have been largely left out of the past year’s parade of biotech businesses onto the public markets, yet on Monday two companies selling devices to treat the very same ailment filed their initial public offering paperwork. Agence ...
Millennials Pretty Sick Of Mean Old Perfesser P... [Published Wonkette - Dec 05 2013]
What’s up, Millennials? Being special snowflakes? We know it is hard out there — we really do! For instance, there are no jobs for you, and that is terrible! Sure, you also have a wee little tendency to yell at your bosses they are not the boss of ...
Free Office collaboration now available; Micros... [Published Security Bloggers Network - Nov 07 2013]
Free Office collaboration now available; Microsoft gives finger to Google #GetItDone  ~ Weirdest. Branding. Evar.  Microsoft (NASDAQ:MSFT) announces new features in Office 365 and the free Office Web Apps. Real-time collaboration is the biggie, but ...
1

Press Releases

sort by: Date | Relevance
Endologix Announces US Launch of the VELA(TM) P... [Published GlobeNewswire: Acquisitions News - Feb 10 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.